CRAYF yields 14.44% · PFE yields 6.20%● Live data
📍 CRAYF pulled ahead of the other in Year 1
Combined, CRAYF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CRAYF + PFE for your $10,000?
Crayon Group Holding ASA, together with its subsidiaries, operates as an IT advisory company in software and digital transformation services. It operates through Software & Cloud Direct, Software & Cloud Channel, Software & Cloud Economics, and Consulting segments. The company provides assess and migrate services, including cloud migration assessment, maturity assessment, cloud infrastructure advisory and migration, cloud POC, cloud tenant migration, cloud connectivity, modern workplace migration, and cloud identity; govern and optimize services comprising IT governance, license optimization, software and cloud economics, and SAM tool; operate and support services, such as modern workplace adoption, software and cloud advisory service desk, and support program services; and data platform and AI solutions services. It also offers software and IT asset management training services. The company has operations in the Nordics, Europe, the Asia-Pacific, the Middle East and Africa, and the United States. Crayon Group Holding ASA is headquartered in Oslo, Norway.
Full CRAYF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.